Celgene Corporation CELG is scheduled to report fourth-quarter 2016 results on Jan 26, before the opening bell. Last quarter, the company reported a positive earnings surprise of 6.11%. Notably, shares of Celgene have outperformed …
A quick analysis of Celgene Corporation (NASDAQ: CELG) stock history reveals three distinct stages with four stock splits along the way. These stages led to the company becoming what the following chart shows it to be -- one of the …
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares …
As expected, Celgene’s recently filed motion focuses on the Coalition’s underlying goal of “profit[ing] by affecting stock prices.” The thrust of Celgene’s motion is that the Coalition’s IPR petitions are “an unwarranted burden on the [PTAB ...
Celgene agreed to pay $232 per share for Receptos, and the companies valued the deal at $7.2 billion excluding Receptos' cash on hand. That's a 12 percent premium from the Tuesday closing price of Receptos shares. The stock
For 2015, Celgene ($CELG) revenue fell in line with Hugin’s performance ... Hugin captured options worth just shy of $8 million, down from $9.61 million in 2014; his stock awards, however, moved upward to $5.43 million from $3.89 million.
Agios Pharmaceuticals, Inc.’s AGIO shares were up almost 26% after the company revealed, in an 8-K filing, that its collaboration partner Celgene Corporation CELG will submit a new drug application (NDA) for enasidenib (AG-221) for …
Leading biotech firm Celgene Corp. said Tuesday it will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics ... of $150 million and buy 9.1 million shares of Juno stock at $93 each, around double what was Juno's …
The tumble in share prices for biotechnology stocks has created some buying opportunities, with drug makers Celgene Corp. and Gilead Sciences poised for a 30 percent rise over the next year, Barron's said. Both companies currently rely …